Neuralink Update – November 2025

Clinical Trial Progress & Results - Neuralink successfully completed its first human trial surgery in the UK, with the participant, Paul, paralyzed due to motor neuron disease (likely ALS), able to control a computer with his thoughts hours after surgery [1][3][4] - Neuralink's total patient count is now 13 across four hospital sites: Phoenix, Miami, Toronto, and London [6] - Neuralink's eighth patient, Nick Ray, demonstrated the ability to control an assisted robotic arm via Bluetooth, showcasing both digital and physical freedom [1][6][9] - Science, a competitor led by Max Hodak, reported that over 80% (26 out of 32) of their study participants experienced meaningful improvement in vision after one year using their 2mm x 2mm retinal implant [2][15][17] Technological Advancements & Applications - Neuralink's device allows patients to control computers and robotic arms with their minds, offering potential for restoring autonomy and enriching daily life [4][5][9] - Neuralink is working towards enabling 22 degrees of freedom of control with Tesla's Optimus robot, expanding beyond the current 7 degrees of freedom with the robotic arm [12] - Neuralink is developing a speech restoration clinical trial study at Cleveland Clinic Abu Dhabi [25] Business Expansion & Strategy - Neuralink has leased a 144,000 sq ft property in South San Francisco, expanding its presence in Silicon Valley in addition to its ongoing expansion in Austin, Texas [2][12] Future Outlook & Developments - Neuralink is expected to begin trials for blindsight next year [18] - Neuralink submitted a paper to the New England Journal of Medicine describing the first three patients implanted with the Neuralink device, including safety data [25]